References
- Schwartz JR. Dexamethasone premedication for prophylaxis of taxane toxicities: can the doses be reduced when paclitaxel or docetaxel are given weekly? J Oncol Pharm Pract 2012;18:250–6.
- Shepherd GM. Hypersensitivity reactions to chemotherapeutic drugs. Clin Rev Allergy Immunol 2003;24:253–62.
- Braverman AS, Rao S, Salvatti ME, Adamson B, McManus M, Pierre S. Tapering and discontinuation of glucocorticoid prophylaxis during prolonged weekly to biweekly paclitaxel administration. Chemotherapy 2005;51:116–19.
- Waffarn F, Davis EP. Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations. Am J Obstet Gynecol 2012;207:446–54.
- Green MC, Buzdar AU, Smith T, Ibrahim NK, Valero V, Rosales MF, et al. Rates of adverse events with low-dose dexamethasone (Dex) as premedication of weekly paclitaxel (Pac) utilized as adjuvant/neoadjuvant therapy for operable breast cancer. In Program and Abstracts of the American Society of Clinical Oncology, 2009 Breast Cancer Symposium, San Antonio, Texas, USA, Abstract 307.
- Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, et al. Hypersensitivity reactions from taxol. J Clin Oncol 1990;8:1263–8.
- Zidan J, Hussein O, Abzah A, Tamam S, Farraj Z, Friedman E. Oral premedication for the prevention of hypersensitivity reactions to paclitaxel. Med Oncol 2008;25:274–8.
- Markman M. Management of toxicities associated with the administration of taxanes. Expert Opin Drug Saf 2003;2:141–6.
- Vardy J, Chiew KS, Galica J, Pond GR, Tannock IF. Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer 2006;94:1011–15.
- Koppler H, Heymanns J, Weide R. Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions. Onkologie 2001;24:283–5.
- Quock J, Dea G, Tanaka M, Gandara D, Lara P, Lau D. Premedication strategy for weekly paclitaxel. Cancer Invest 2002;20:666–72.
- Hainsworth JD. Practical aspects of weekly docetaxel administration schedules. Oncologist 2004;9:538–45.
- Zhou JN, Huang XE, Ye Z, Li C, Zhang Q, Lin Y, et al. Weekly paclitaxel/docetaxel combined with a platinum in the treatment of advanced non-small cell lung cancer: a study on efficacy, safety and pre-medication. Asian Pac J Cancer Prev 2009;10:1147–50.
- Stemmler HJ, Stauch M, Papke J. Weekly docetaxel with or without corticosteriod premedication as first or second–line treatment in patients with metastatic breast cancer. Proc Am Soc Clin Oncol 2002;21:231–8.
- Sparano JA, Wang M, Martino S, Jones V, Perez EA, Saphner T, et al. Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 2008;358:1663–71.